Apple Watch blood pressure feature reportedly under FDA review

The Apple Watch is once again being linked with blood pressure tracking, but the latest claim is not quite the breakthrough some users want. The report points to a high blood pressure notification feature under FDA review, which sounds useful but still short of full cuff-style readings.

A familiar feature with a possible twist

The awkward part is that Apple already has hypertension notifications. These arrived with watchOS 26 and use the optical heart sensor to analyse how blood vessels respond over time, looking for patterns that may suggest high blood pressure.

This new report from Digitimes describes another high blood pressure notification feature that also appears to use the optical heart-rate sensor on the back of the watch. That makes the distinction slightly muddy. It could mean Apple has a more clinically validated version waiting for regulatory clearance, or it could mean the existing feature has a more advanced implementation tied to newer hardware.

The report says the feature remains under FDA review. That is the key bit here. It suggests Apple may have something it does not yet want to switch on publicly, either because it needs clearance or because it wants to launch it with the next Apple Watch generation.

For users, the obvious question is whether this means real blood pressure readings. Right now, it does not sound like that. The wording points to notifications rather than systolic and diastolic numbers, so this still looks more like pattern detection than cuff-style measurement.

Ultra 4 may be the bigger story

The same report links the health feature to Apple Watch Ultra 4, which is expected to bring a redesign and upgraded sensing hardware. Previous supply chain chatter has pointed to exterior changes and a new rear sensor arrangement, including a ring-like layout with more sensors.

That would make sense if Apple wants better signal quality from the underside of the watch. Blood pressure estimation is difficult from the wrist, especially if Apple wants to avoid a cuff. Better optical hardware could help Apple detect vascular patterns more reliably, even if it still stops short of giving full blood pressure values.

Still, the report does not clearly say whether older models will support it. That point needs caution. Apple may bring the feature to several models if the existing optical sensor can handle it, or it may reserve the improved version for new watches with updated hardware.

The blood glucose line needs caution

The report also mentions noninvasive blood glucose monitoring as Apple’s next stage after high blood pressure notifications. That sounds exciting, but it also needs a large pinch of salt.

Apple has worked on noninvasive glucose monitoring for years. The technical challenge remains huge because glucose measurement needs accuracy in a way that general wellness trends do not. A weak or inconsistent reading could create more problems than it solves.

So this should not be read as a sign that Apple Watch Ultra 4 will suddenly measure blood glucose. The safer reading is that Apple continues to work on it and that regulatory approval would be needed before anything public appears.

Useful, but not the full answer yet

The frustration is that Apple Watch blood pressure rumours have been around for years. Many people want actual readings, not another alert that tells them to use a cuff. That is understandable, especially when cheaper wearables often claim to offer blood pressure numbers, even if the reliability can be questionable.

Apple tends to move slower in health because it usually wants regulatory cover and a defensible method. That can make the Watch feel behind rivals on spec sheets, but it also reduces the chance of pushing out a feature that creates false confidence.